Treatment for Gestational Diabetes Mellitus (GDM)

Phase-Based Progress Estimates
Lynn Community Health Center, Lynn, MA
Gestational Diabetes Mellitus (GDM)+2 More
18 - 65
What conditions do you have?

Study Summary

The investigators will conduct a pre-post study to evaluate the effectiveness of the Hola Bebe intervention on improving self-efficacy for healthy eating and physical activity, and on weight loss among Hispanic women with recent GDM. The Hola Bebe app provides a unique opportunity to provide an effective, culturally tailored lifestyle modification program. The investigators will provide training to health educators at the two participating sites to ensure consistency and fidelity of implementation.

Eligible Conditions

  • Gestational Diabetes Mellitus (GDM)

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Gestational Diabetes Mellitus (GDM)

Study Objectives

2 Primary · 1 Secondary · Reporting Duration: up to 6 month

up to 6 month
Sallis Self Efficacy for Physical Activity
up to 6 months
HbA1C level
Sallis Self Efficacy for Healthy Eating
Weight loss

Trial Safety

Safety Progress

1 of 3

Other trials for Gestational Diabetes Mellitus (GDM)

Trial Design

0 Treatment Group

150 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: up to 6 month
Closest Location: Lynn Community Health Center · Lynn, MA
Photo of massachusetts 1Photo of massachusetts 2Photo of massachusetts 3
N/AFirst Recorded Clinical Trial
1 TrialsResearching Gestational Diabetes Mellitus (GDM)
0 CompletedClinical Trials

Who is running the clinical trial?

Environment and Health Group, Inc.Lead Sponsor
7 Previous Clinical Trials
762 Total Patients Enrolled
1 Trials studying Gestational Diabetes Mellitus (GDM)
18 Patients Enrolled for Gestational Diabetes Mellitus (GDM)
Dharma CortesPrincipal InvestigatorEnvironment and Health Group, Inc.

Eligibility Criteria

Age 18 - 65 · Female Participants · 5 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are between the ages of 18 and 45.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.